questioned by Antoniades et al. (1979) . The present investigation was therefore undertaken to improve the procedure for the isolation of PDGF. Large amounts of PDGF (500,ug, from 600 litres of blood) were obtained without the use of SDS; analytical SDS/polyacrylamide-gel electrophoresis indicated that the product was essentially pure. Sedimentation-equilibrium analysis in the ultracentrifuge yielded a molecular weight of about 33000, thus corroborating the two-chain molecular model for PGDF suggested previously (Heldin et al., 1979) .
Materials and methods Assayfor multiplication-stimulating activity
Multiplication-stimulating activity was estimated by using the incorporation of [3Hlthymidine into trichloroacetic acid-precipitable material of serumdeprived sparse cultures of a normal human glial cell line, U-787 CG (Ponten & Macintyre, 1968) as described by Heldin et al. (1977) . Multiplicationstimulating activity was expressed relative to the activity given by medium containing 1% (v/v) of a reference serum derived from a pool of healthy human subjects. The reference assay resulted in 0306-3275/81/030907-07$01.50/1 X 1981 The Biochemical Society 2G 7000-12000 c.p.m. per dish, corresponding to 5 5-80% of nuclei labelled as determined by radioautography (Heldin et al., 1977) . Controls receiving no multiplication-stimulating activity incorporated 500-2000c.p.m. per dish (3-10% of nuclei labelled).
Purification ofPDGF
Platelet lysate. Platelets were obtained in large quantities through the courtesy of the Finnish Red Cross, Helsinki. Blood collected from healthy donors, with citrate as anticoagulant, was centrifuged at 6400g for 4min. The 'buffy coats' and erythrocytes were removed and used for other purposes. Platelets remaining in the supernatant (about 20-25% of the total platelets) were pelleted by another centrifugation at 6400g for 10min. The pellets were pooled and stored at -20°C and used as starting material in our purification procedure. Usually platelets from 500 donors (about 1013 platelets) were processed simultaneously. During the handling, plastic containers or silicone-treated glassware were used to minimize losses of PDGF on vessel walls. After thawing, the platelets were suspended in 2 litres of distilled water (2ml/1010 platelets) and disintegrated by freezing and thawing five times. Then 1 litre of 1M-NaCl/O.OlM-sodium phosphate buffer, pH 7.4, was added and the suspension centrifuged at 100 0Og for 1h at 40C.
The supernatant was then processed essentially as described by Heldin et al. (1979) , by CM-Sephadex chromatography and Blue Sepharose chromatography. All operations were performed at 40C, unless otherwise specified.
CM Pharmacia) at a flow rate of 15 ml/h. The column was washed with about 200ml of 1 M-NaCl/0.01 Mphosphate buffer, pH 7.4, and finally eluted with 60ml of 50% (v/v) ethylene glycol containing 1 M-NaCl and 0.01 M-phosphate buffer, pH 7.4. A major portion of the multiplication-stimulating activity was recovered in the latter step and used for further purification.
Bio-Gel P-150 chromatography. PDGF purified on Blue Sepharose was dialysed against 1 M-acetic acid and freeze-dried. The material (9 mg of protein) was dissolved in 3 ml of 1 M-acetic acid. A small precipitate was removed by centrifugation; the material was then applied to a column (2 cm x 145 cm) of Bio-Gel P-1 50 (100-200 mesh; Bio-Rad) equilibrated with 1 M-acetic acid. Elution was performed at room temperature at a flow rate of 8 ml/h. Effluent fractions were analysed for protein and multiplication-stimulating activity ( Fig. 1) .
Sephadex G-200 chromatography. Active fractions from three Bio-Gel P-150 chromatographies were pooled as shown in Fig. 1 and freeze-dried. The material (1.2mg of protein) was dissolved in 0.8ml of 1 M-acetic acid and applied to a column (1 cm x 145 cm) of Sephadex G-200 (fine grade; Pharmacia) equilibrated with 1 M-acetic acid. The column was operated at room temperature at a flow rate of 3 ml/h. The effluent was analysed for protein and multiplication-stimulating activity (Fig. 2) . PDGF pooled as indicated in Fig. 2 was used in further analyses.
Electrophoresis
Analytical SDS/polyacrylamide-gel electrophoresis was performed by the method of Laemmli (1970), as described by Heldin et al. (1979) , at a gel concentration of 12% acrylamide. After the run, the gels were stained with Amido Black (5g/l in 7% acetic acid) or Coomassie Brilliant Blue R-250 (2.5 g/l in 10% acetic acid/45% methanol) and scanned at 570nm in a Gilford spectrophotometer 250. Alternatively gels were sliced, extracted and assayed for multiplication-stimulating activity. The molecular-weight markers were as described by Heldin et al. (1979) .
Amino acid analysis
Amino acid analyses were performed in a Beckman 121M analyser. Samples (30,ug of PDGF per analysis) were hydrolysed in 6 M-HCl at 1 10°C for 24 h or 72 h. Values for serine and threonine were obtained by extrapolation to zero time, whereas valine and isoleucine were determined after 72 h of hydrolysis. Cysteine and methionine were determined after oxidation in performic acid. For tryptophan determinations, samples were hydrolysed in 4 M-methanesulphonic acid at 1 10°C for 24h.
Ultracentrifugation Sedimentation-equilibrium analysis (Chervenka, 1970) was performed in a Beckman model E analytical ultracentrifuge equipped with interference optics. The experiments were performed in capillary-type double-sector cells at a rotor speed of 28000rev./min. PDGF purified through the Sephadex G-200 step was freeze-dried and dissolved in 1 M-NaCl/1 M-acetic acid. Three different concentrations of PDGF were used: 0.6, 0.5 and 0.3 mg/ml. The partial specific volume of PDGF was calculated from its amino acid composition (Schachman, 1957) .
Results

Purification
The present procedure for the purification of PDGF from human platelets ( Table 1 ) differs from that previously reported (Heldin et al., 1979) in the following respects: fresh rather than outdated platelets were used, the batch size was increased by a factor of 20 and preparative SDS/polyacrylamidegel electrophoresis was omitted. Although the specific activity of the present platelet lysate from fresh platelets was somewhat lower than that obtained in the previous procedure (Heldin et al., 1979) , probably owing to heavy admixture of plasma proteins, a higher specific activity was reached in the CM-Sephadex step. Therefore the use of fresh platelets not only increased the amount of available starting material per platelet, but also led to a more favourable contaminant situation. This was also apparent in the subsequent steps, Blue Sepharose and Bio-Gel P-150 chromatography (Fig. 1) , both resulting in higher specific activities than in the previous procedure. The final Sephadex G-200 chromatography was undertaken after combining three individual Bio-Gel P-150 pools to ensure sufficient protein load (Fig. 2) . The resulting 540,ug of PDGF contained 6% of the original activity; the potency of this preparation was such that 2ng/ml was equivalent to the growth-promoting activity of 1% human serum (Fig. 3) . This specific activity is about twice that obtained with the previous preparation of PDGF (Heldin et al., 1979) ; however, the discrepancy is probably due to uncertainty in the determination of the protein concentration of the latter preparation. The recovery of PDGF (about 6%) may appear low, but compares favourably with that reported previously Heldin et al., 1979.) . Each individual step showed a total recovery (before pooling) of 65% or better. It should also be noted that the biological activity of the starting material, on which the calculation of recovery was based, included anionic material with a distinct growth-promoting activity (Heldin et al., 1979) ; therefore the recovery of cationic PDGF was about twice that indicated in Table 1 .
Electrophoresis
Gel electrophoresis of PDGF in the presence of SDS revealed the presence of a single Amido Black-stainable band, with migration properties conforming to those of a 30000-dalton protein (Fig.  4) M-acetic acid of PDGF pooled from three individual Bio-Gel P-150 chromatographies (Fig. I) A 1.2mg sample of protein was applied to a2 cm x 145 cm column. The effluent was analysed for protein (0)and multiplication-stimulating activity (0).In the latter assay, samples were tested at a final dilution of 1:2500 and the result was expressed as described in the legend to Fig. b (see also the comments in the legend to Fig. 1 ). The three most active fractions were pooled as indicated.
destroy the biological activity, the 30.000-dalton Amino acid analysis component disappeared, giving rise to two fastermoving bands, with mol.wts.17v000 and 14000
Amino acid analysis indicated that PDGF conrespectively. tained all the common amino acids except trypto- PDGF (ng/ml) 50 100 Fig. 3 . Dose-dependent biological activity of purified PDGF The multiplication-stimulating activity (expressed as described in the legend to Fig. 1 ) was recorded as a function of the concentration of PDGF, purified as described in Table 1 . Table 1 , was run under non-reducing conditions and assayed for multiplication-stimulating activity (expressed as described in the legend to Fig. 1 
Ultracentrifugation
Sedimentation-equilibrium analysis of PDGF in 1 M-acetic acid/i M-NaCl indicated homogeneity and yielded similar molecular weights (mean 32 700 daltons) at three different concentrations (Fig. 5) . of PDGF, probably owing to charge effects of the strongly cationic protein.
Discussion
We have previously suggested that the molecular weight of unreduced PDGF is about 30000. This value was based on the migration of PDGF in polyacrylamide-gel electrophoresis in the presence of SDS (Heldin et al., 1977 (Heldin et al., , 1979 . It may be argued that, since a cationic unreduced protein may bind proportionally less SDS than do standard proteins (Weber & Osborn, 1975) , the molecular weight of PDGF may have been overestimated in this analytical system. The analysis of PDGF in the reduced form was only performed with 'l25-labelled PDGF; the available amounts of material were so small that the migration of the reduction products could not be satisfactorily determined by protein staining. Antoniades et al. (1979) obtained essentially confirmatory data, finding a mobility of unreduced biologically active PDGF corresponding to a molecular weight of 35000-38000. However, these authors were inclined to have more confidence in a much lower molecular-weight value, 13000-16000, obtained by chromatography of PDGF on Bio-Gel P-150 in the presence of 1 M-acetic acid and by SDS/polyacrylamide-gel electrophoresis performed under reducing conditions. To solve this controversy, we considered it necessary to prepare sufficient amounts of PDGF to permit an independent physical-chemical analysis. From large amounts of fresh platelets about 0.5mg of PDGF was obtained. In contrast with previous preparations Heldin et al., 1979) , this material had not been exposed to SDS. A single band was observed in analytical SDS/polyacrylamide-gel electrophoresis under non-reducing conditions (Fig. 4) ; also no inhomogeneity was detectable by ultracentrifugation (Fig. 5) . Sedimentation-equilibrium analysis resulted in a molecular weight of about 33000, in accordance with values obtained by SDS/polyacrylamide-gel electrophoresis. Moreover, reduction of PDGF produced two distinct stainable components with moelcular weights 17000 and 14000 (Fig. 4) . The molecular model implicated by these findings is that PDGF is composed of two different polypeptide chains, covalently linked to make up a total molecular weight of slightly more than 30000. Disulphide bridges are probably involved in the assembly of the PDGF molecule, since, along with the formation of the two polypeptide chains on reduction, the biological activity is irreversibly destroyed, whereas under non-reducing conditions the biological activity is highly stable to denaturing agents. Amino acid analysis indicated that enough half-cystine residues were present to account for five disulphide bridges. The relation between the two constituent chains is not known; one may speculate that they have been formed by proteolytic cleavage of a single-chain precursor molecule. Such a modification may either be a specific event in the life cycle of PDGF (e.g. activation) or be a non-specific but limited degradation during the preparation.
